IE1-pp65 recombinant protein from human CMV combined with a nanoparticulate carrier, SMBV, as a potential source for the development of anti-human CMV adoptive immunotherapy

Author: Vaz-Santiago J   Lulé J   Rohrlich P   Kravtzoff R   Le Roy E   Davignon J-L   Betbeder D   Davrinche C  

Publisher: Ashgate Publishing Ltd

ISSN: 1465-3249

Source: Cytotherapy, Vol.4, Iss.1, 2002-01, pp. : 11-19

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content